Phase II/III randomized trial of exclusive chemoradiotherapy with or without dose escalation in locally advanced esophageal carcinoma: The CONCORDE study (PRODIGE 26).
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Phase II/III randomized trial of exclusive chemoradiotherapy with or without dose escalation in locally advanced esophageal carcinoma: The CONCORDE study (PRODIGE 26). |
Type de publication | Journal Article |
Year of Publication | 2016 |
Auteurs | Crehange G, Bonnetain F, Peiffert D, Le Prise E, Etienne P-L, Rio E, Pereira R, Noel G, Benezery K, Seitz JFrancois |
Journal | JOURNAL OF CLINICAL ONCOLOGY |
Volume | 34 |
Date Published | FEB 1 |
Type of Article | Meeting Abstract |
ISSN | 0732-183X |
DOI | 10.1200/jco.2016.34.4_suppl.tps190 |